Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Victor W. Sung"'
Autor:
Victor W. Sung, Sanjay K. Gandhi, Victor Abler, Brian Davis, Debra E. Irwin, Karen E. Anderson, Ravi G. Iyer
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 6, Iss 1 (2018)
**Background:** Huntington’s disease (HD) is a multifaceted neurodegenerative disorder characterized by involuntary movements, specifically chorea, as well as behavioral and psychiatric disturbance, and cognitive dysfunction. Tetrabenazine was the
Externí odkaz:
https://doaj.org/article/5561f5b9136949d58a9f72be8f228581
Autor:
Melanie Benge, Amie L. Hiller, Carolyn Gray, Michele Costigan, H. Diana Rosas, Stephanie Lowenhaupt, Rosalind S Chuang, Peter Hedera, Danny Bega, Matthew J. Barrett, Marianne Chase, Jon W. Yankey, Jessica Lamb, Elaine Sperin, Susan Perlman, Christina Gruenwald, Joseph F. Quinn, Joyce Ann Moran, Lauren Seeberger, Debra E Itzkowitz, Brenton A Wright, Kelly Lowen, Karen E. Anderson, Victor W. Sung, Angela Molloy, Frederick J. Marshall, Patricia Conlon, Hilda T Maibach, Jamie L Adams, Elaine Most, Stewart A. Factor, Karen Marder, Allison M. Daley, Shifang Lu, Carlos Singer, Michael J Brownstein, Neal G. Simon, Amy M Chesire, Valerie Suski, Codrin Lungu, Kellie Keith, Christopher S. Coffey, Guy J Schwartz, Zsazsa R Brown, Richard Dubinsky, Catherine Gladden, Paola Wall, Jeremy M. Shefner, Steven M. Hersch, Cara Jacob, Jeffrey D. Long, Dixie Ecklund, Padraig E. O'Suilleabhain, Andrew P. Duker, J. Singleton, Meghan Zorn, Carolyn Drazinic, Mark Quigg, Eve M Damiano, Sandra K. Kostyk, Brenda Thornell, Andrew McGarry, Merit Cudkowicz, Robin Conwit, Paul Deritis, Joel S. Perlmutter
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 11
Journal of Clinical Medicine, Vol 9, Iss 3682, p 3682 (2020)
Volume 9
Issue 11
Journal of Clinical Medicine, Vol 9, Iss 3682, p 3682 (2020)
SRX246 is a vasopressin (AVP) 1a receptor antagonist that crosses the blood-brain barrier. It reduced impulsive aggression, fear, depression and anxiety in animal models, blocked the actions of intranasal AVP on aggression/fear circuits in an experim
Autor:
Debra E. Irwin, Victor W. Sung, Victor Abler, Sanjay Gandhi, Brian Davis, Karen E. Anderson, Ravi Iyer
Publikováno v:
Journal of Health Economics and Outcomes Research
**Background:** Huntington’s disease (HD) is a multifaceted neurodegenerative disorder characterized by involuntary movements, specifically chorea, as well as behavioral and psychiatric disturbance, and cognitive dysfunction. Tetrabenazine was the
Autor:
Victor W. Sung, Marissa Dean
Publikováno v:
Drug Design, Development and Therapy. 12:313-319
Deutetrabenazine was recently approved for the treatment of chorea in Huntington's disease (HD) and is the first deuterated medication that has been US Food and Drug Administration (FDA)-approved for therapeutic use. In this article, we review deutet
Autor:
Aimee Dietz, Victor W. Sung, Xiaohua Zhou, Joseph C. Griffis, Amber N. Martin, Rodolphe Nenert, Victor W. Mark, Harrison C. Walker, Christopher J. Lindsell, Jerzy P. Szaflarski, Jane B. Allendorfer, Amy W. Amara
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Research indicates intermittent theta burst stimulation (iTBS) is a potential treatment of post-stroke aphasia. MATERIAL AND METHODS In this double-blind, sham-controlled trial (NCT01512264) participants were randomized to receive 3 weeks
Publikováno v:
The Journal of pediatrics. 213
Autor:
Ravi Iyer, Victor Abler, Marco DiBonaventura, Bijal Shah-Manek, Victor W. Sung, Daniel O. Claassen
Publikováno v:
Journal of Huntington's disease. 7(4)
BACKGROUND Huntington disease (HD) is a neurodegenerative disorder characterized by motor impairments (including chorea), along with behavioral, psychiatric, and cognitive symptoms. Tetrabenazine was the first US Food and Drug Administration (FDA)-ap
Autor:
Xiaohua Zhou, Victor W. Sung, Jane B. Allendorfer, Jerzy P. Szaflarski, Jennifer Vannest, Harrison C. Walker, Joseph C. Griffis, Amber N. Martin, Amy W. Amara, Rodolphe Nenert, Victor W. Mark
Publikováno v:
Restorative neurology and neuroscience. 36(4)
Purpose The purpose of this feasibility study was to assess whether combined intermittent theta burst suppression (iTBS) applied to the ipsilesional hemisphere and modified constraint-induced aphasia therapy (mCIAT) are safe and logistically feasible
Autor:
Marissa, Dean, Victor W, Sung
Publikováno v:
Drug Design, Development and Therapy
Deutetrabenazine was recently approved for the treatment of chorea in Huntington’s disease (HD) and is the first deuterated medication that has been US Food and Drug Administration (FDA)-approved for therapeutic use. In this article, we review deut
Autor:
Victor Abler, Sanjay Gandhi, Ravi Iyer, Daniel O. Claassen, Victor W. Sung, Bijal Shah-Manek, Marco DiBonaventura
Objective: To survey neurologists and obtain clinical perceptions of tetrabenazine for the treatment of chorea in patients with Huntington disease (HD). Methods: Board-certified/board-eligible neurologists, in practice for ≥5 years, who had treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a0c57f51e6e371265a0f26f69b020d